Marvelon

Desogestrel, the active ingredient in Marvelon, together with ethinylestradiol, is a combined oral contraceptive presented as 150 µg desogestrel / 30 µg ethinylestradiol oral tablet for oral use. It prevents pregnancy in women of reproductive age and is taken as part of a monthly cycle to maintain contraceptive efficacy.

GNH USA supplies Marvelon as a licensed, GDP‑compliant international pharmaceutical supplier, delivering the product through regulated distribution channels to hospitals, pharmacies and clinics worldwide, and complies with all relevant stringent EU quality standards.

Marvelon, a combined oral contraceptive, is used within the hormonal contraception pathway to prevent pregnancy. - Prevention of pregnancy: provides reliable contraceptive protection when taken daily as directed. - Menstrual cycle regulation: helps achieve more predictable bleeding patterns and may reduce menstrual cramps. - Acne management: can improve mild to moderate acne by reducing circulating androgen levels.

Marvelon may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nausea: mild stomach upset, often improves after the first cycle. - Headache: tension‑type or migraine‑like pain. - Breast tenderness: swelling or soreness of the breasts. - Weight gain: modest increase due to fluid retention. - Mood changes: irritability or mild depressive symptoms. - Breakthrough bleeding: spotting between periods.

Serious or Rare Side Effects: - Venous thromboembolism: blood clots in deep veins or lungs. - Arterial thrombosis: clot formation in arteries, potentially causing stroke or heart attack. - Hypertension: elevated blood pressure requiring monitoring. - Liver dysfunction: abnormal liver enzymes or jaundice. - Severe allergic reaction: rash, swelling, or anaphylaxis. - Visual disturbances: sudden vision loss or blurred vision.

Before prescribing Marvelon, clinicians should evaluate individual risk factors and counsel patients on safe use. - Assess cardiovascular risk: review history of thrombosis, smoking, hypertension, and obesity. - Avoid use in smokers over 35 years: increased risk of serious clotting events. - Consider liver function: contraindicated in active liver disease or severe hepatic impairment. - Monitor blood pressure: oral contraceptives may raise systolic and diastolic values. - Review medication list: certain enzyme‑inducing drugs can reduce contraceptive efficacy. - Store at ambient temperature: keep below 25 °C, in the original pack, and protect from moisture.

Marvelon can interact with other medicines, altering its effectiveness or safety profile.

Major Interactions (Avoid): - Antiepileptic enzyme inducers (e.g., carbamazepine, phenytoin): may markedly reduce hormonal levels and contraceptive protection. - Rifampicin: decreases ethinylestradiol concentrations, increasing risk of unintended pregnancy. - Protease inhibitor ritonavir: can raise hormone levels, heightening the chance of thrombotic events.

Moderate Interactions (Monitor Closely): - Broad‑spectrum antibiotics (e.g., ampicillin, tetracycline): may slightly diminish contraceptive efficacy. - St. John’s wort: herbal inducer that can lower hormone concentrations. - Thiazide diuretics: may exacerbate blood‑pressure‑raising effects of the estrogen component.